An enzyme that catalyzes the eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups. (Enzyme Nomenclature, 1992)
Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C.
Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.
A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed)
A mucopolysaccharide constituent of chondrin. (Grant & Hackh's Chemical Dictionary, 5th ed)
Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains.
Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine or N-acetylgalactosamine.
Glycoproteins which have a very high polysaccharide content.
A small leucine-rich proteoglycan that interacts with FIBRILLAR COLLAGENS and modifies the EXTRACELLULAR MATRIX structure of CONNECTIVE TISSUE. Decorin has also been shown to play additional roles in the regulation of cellular responses to GROWTH FACTORS. The protein contains a single glycosaminoglycan chain and is similar in structure to BIGLYCAN.
Inorganic salts of sulfuric acid.
Unstable isotopes of sulfur that decay or disintegrate spontaneously emitting radiation. S 29-31, 35, 37, and 38 are radioactive sulfur isotopes.
Enzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. EC 4.2.2.-.
Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
An enzyme that, in the presence of ATP and COENZYME A, catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and ORTHOPHOSPHATE. This reaction represents an important step in fatty acid biosynthesis. This enzyme was formerly listed as EC 4.1.3.8.
A group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. EC 4.2.2.
Oligosaccharides containing two monosaccharide units linked by a glycosidic bond.
An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyzes the conversion of 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. EC 4.3.2.2.
A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.
Enzymes that catalyze the cleavage of a carbon-carbon bond of a 3-hydroxy acid. (Dorland, 28th ed) EC 4.1.3.
A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS.
A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.
An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS.
A sulfated mucopolysaccharide initially isolated from bovine cornea. At least two types are known. Type I, found mostly in the cornea, contains D-galactose and D-glucosamine-6-O-sulfate as the repeating unit; type II, found in skeletal tissues, contains D-galactose and D-galactosamine-6-O-sulfate as the repeating unit.
A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. (Enzyme Nomenclature, 1992) EC 4.
Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2.
Enzymes that catalyze a reverse aldol condensation. A molecule containing a hydroxyl group and a carbonyl group is cleaved at a C-C bond to produce two smaller molecules (ALDEHYDES or KETONES). EC 4.1.2.
Acids derived from monosaccharides by the oxidation of the terminal (-CH2OH) group farthest removed from the carbonyl group to a (-COOH) group. (From Stedmans, 26th ed)
HYALURONAN-containing proteoglycans found in the EXTRACELLULAR MATRIX of a variety of tissues and organs. Several versican isoforms exist due to multiple ALTERNATIVE SPLICING of the versican MESSENGER RNA.
Large HYALURONAN-containing proteoglycans found in articular cartilage (CARTILAGE, ARTICULAR). They form into aggregates that provide tissues with the capacity to resist high compressive and tensile forces.

Repopulation of different layers of host human Bruch's membrane by retinal pigment epithelial cell grafts. (1/194)

PURPOSE: To determine the morphology of human retinal pigment epithelium (RPE) after reattachment to different ultrastructural layers of human Bruch's membrane (BM). METHODS: Bruch's membrane explants were prepared from eyes of 23 human donors (age range, 11-89 years). The basal lamina of the RPE, inner collagenous layer, and elastin layer were removed sequentially by mechanical and enzymatic techniques. First-passage cells of human RPE (15,000 cells/6 mm explant) from three donors (ages, 52, 64, and 80 years) were plated onto different layers of human BM, and the explants were examined by scanning and transmission electron microscopy up to 21 days later. RESULTS: RPE flattened and extended footplates 6 hours after plating onto basal lamina. Cells remained round 6 and 24 hours after plating onto the inner collagenous, elastin, or outer collagenous layer. The RPE cells became confluent 14 days after plating onto basal lamina but did not become confluent up to 21 days after plating onto the inner collagenous or elastin layer. Sparse round cells were observed 21 days after plating onto deeper layers, suggesting extensive loss of RPE. CONCLUSIONS: The morphology and subsequent behavior of the RPE reattached to BM depends on the anatomic layer of BM available for cell reattachment. The results suggest that the ability of transplanted RPE to repopulate BM in age-related macular degeneration and other disorders may depend on the layer of BM available to serve as a substrate for cell reattachment.  (+info)

Glycosaminoglycans differentially bind HARP and modulate its biological activity. (2/194)

Heparin affin regulatory peptide (HARP) is a polypeptide belonging to a family of heparin binding growth/differentiation factors. The high affinity of HARP for heparin suggests that this secreted polypeptide should also bind to heparan sulfate proteoglycans derived from cell surface and extracellular matrix defined as extracellular compartments. Using Western blot analysis, we detected HARP bound to heparan sulfate proteoglycans in the extracellular compartments of MDA-MB 231 and MC 3T3-E1 as well as NIH3T3 cells overexpressing HARP protein. Heparitinase treatment of BEL cells inhibited HARP-induced cell proliferation, and the biological activity of HARP in this system was restored by the addition of heparin. We report that heparan sulfate, dermatan sulfate, and to a lesser extent, chondroitin sulfate A, displaced HARP bound to the extracellular compartment. Binding analyses with a biosensor showed that HARP bound heparin with fast association and dissociation kinetics (kass = 1.6 x 10(6) M-1 s-1; kdiss = 0.02 s-1), yielding a Kd value of 13 nM; the interaction between HARP and dermatan sulfate was characterized by slower association kinetics (kass = 0.68 x 10(6) M-1 s-1) and a lower affinity (Kd = 51 nM). Exogenous heparin, heparan sulfate, and dermatan sulfate potentiated the growth-stimulatory activity of HARP, suggesting that corresponding proteoglycans could be involved in the regulation of the mitogenic activity of HARP.  (+info)

Sulfation of chondroitin sulfate in human articular cartilage. The effect of age, topographical position, and zone of cartilage on tissue composition. (3/194)

The chondroitin ABC lyase digestion products of normal human femoral condyle articular cartilage and of purified aggrecan were analyzed for their mono- and nonsulfated disaccharide composition. Changes in the total tissue chemistry were most pronounced during the period from birth to 20 years of age, when the -[GlcAbeta,3GalNAc6]- disaccharide content increased from approximately 50% to 85% of the total disaccharide content and there was a concomitant decrease in the content of the 4-sulfated disaccharide. In general, the disaccharide content of the deeper layers of immature cartilage were richer in the 4-sulfated residue than the upper regions of the tissue. As the tissue aged and decreased in thickness, the disaccharide composition became more evenly 6-sulfated. The newly synthesized chondroitin sulfate chains had a similar composition to the endogenous chains and also underwent the same age and zonal changes. The monoclonal antisera 3B3(+) and 2B6(+) were used to immunolocalize the unsaturated 6- and 4-sulfated residues generated at the reducing termini of the chondroitin sulfate chains by digestion with chondroitin ABC lyase, and these analyses indicated that the sulfation pattern at this position did not necessarily reflect the internal disaccharide composition of the chains. In summary, the sulfation pattern of chondroitin sulfate disaccharides from human normal articular cartilage varies with the age of the specimen, the position (topography) on the joint surface, and the zone of cartilage analyzed. Furthermore, these changes in composition are a consequence of both extracellular, post-translational processing of the core protein of aggrecan and changes in the sulfotransferase activity of the chondrocyte.  (+info)

Molecular polymorphism of the syndecans. Identification of a hypo-glycanated murine syndecan-1 splice variant. (4/194)

We have identified a cDNA that encodes a variant form of murine syndecan-1. The variant cDNA lacks the sequence corresponding to the first 132 nucleotides of the third exon of the syndecan-1 gene. The corresponding message is rare. The alternative splice respects the reading frame and deletes 44 amino acids from the protein, joining the S45GS47GT sequence to a variant immediate downstream context. This sequence context initiates with alanine instead of glycine as residue 50, reducing the number of SGXG sequence motifs in the protein from two to one. Expression of this variant syndecan-1 in Madin-Darby canine kidney or MOLT-4 cells yielded a recombinant proteoglycan with a reduced number and clustering of the heparan sulfate chains. Both the conversions of Ala50 and of Lys53 into glycine enhanced the heparan sulfate substitution of the variant protein. These findings support the concept that serine-glycine dipeptide signals for glycosaminoglycan/heparan sulfate synthesis depend on sequence context (Zhang, L., David, G., and Esko, J. D. (1995) J. Biol. Chem. 270, 27127-27135) and imply that alternative splicing mechanisms may in part control the molecular polymorphism of syndecan-1 and, therefore, the efficiency and versatility of this protein in its co-receptor functions.  (+info)

Quantitative alterations of hyaluronan and dermatan sulfate in the hairless mouse dorsal skin exposed to chronic UV irradiation. (5/194)

The quantitative alterations of hyaluronan and dermatan sulfate in the upper dermis (fibrous tissue) and the lower dermis (adipose tissue) of the hairless mouse skin chronically exposed to the UV irradiation as solar-simulating irradiation (lambda(max) 352 nm, UV distribution: 300-310 nm, 0.9%; 310-320 nm, 2.0%; 320-420 nm, 97.1%) were evaluated. Hyaluronan and dermatan sulfate contents in each part of dermis were determined as follows: skin sections on a glass slide prepared by histological technique were processed into the upper dermis and the lower dermis with a small surgical knife, and treated with chondroitinase ABC and ACII in the presence of bacterial collagenase. The resulting unsaturated disaccharides were determined by HPLC method. By applying this method to the UV-irradiated hairless mouse skin, it was found that the chronic UV irradiation increased dermatan sulfate in the upper dermis, whereas an increase of hyaluronan content was not statistically significant. In the lower dermis, on the contrary, both hyaluronan and dermatan sulfate contents remarkably increased as compared with the control mice. Furthermore, the histological study showed the accumulation of the collagen fibers in the lower dermis of the UV-irradiated hairless mouse skin following the disappearance of adipocytes. These findings indicate that the increases of glycosaminoglycan contents in the UV-irradiated skin are related to the accumulation of the extracellular matrix components in the lower dermis.  (+info)

Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan. (6/194)

A monoclonal antibody was used in early studies to identify a novel chondroitin sulfate proteoglycan, secreted by L-2 cells, the core protein of which was approximately 100 kDa. To characterize this proteoglycan core protein at the molecular level, an L-2 cell cDNA library was probed by expression screening and solution hybridization. Northern blot analysis assigned transcript size to approximately 3.1 kilobases and, after contig assembly, the coding region of the mRNA corresponded to 2.18 kilobases. Immunoassays were performed to confirm the identity of this sequence, using a polyclonal antibody raised against an expressed fusion protein encoded by sequence representing the carboxyl half of the molecule. The antibody recognized the core protein in Western blots after prior digestion of the intact proteoglycan with chondroitinase ABC. Immunostaining tissue sections with the same antibody localized the proteoglycan to basement membranes, and expression of the entire sequence in Chinese hamster ovary K-1 cells showed that the protein encoded by the sequence secreted as a chondroitin sulfate proteoglycan. The core protein not only has motifs permitting glycosylation as a proteoglycan, but also possesses the endoplasmic reticulum retrieval signal, KDEL, which suggests that, in addition to its role as a basement membrane component, it may also participate in the secretory pathway of cells.  (+info)

Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel. (7/194)

PURPOSE: To determine the effects of enzymes on mammalian vitreous gel and to thus infer the structural roles of hyaluronan and chondroitin sulfate in the gel. METHODS: The wet weights of bovine vitreous gels were compared before and after incubation with Streptomyces hyaluronan lyase, chondroitin ABC lyase, testicular hyaluronidase, or buffer alone. The extent of hyaluronan depolymerization was determined by chromatography and that of chondroitin sulfate depolymerization by western blot analysis. RESULTS: After digestion with Streptomyces hyaluronan lyase (30 U/gel), the gel wet weight was the same as that of controls (incubated with buffer alone) despite 94% of the hyaluronan having been depolymerized; when digested with 100 U/gel, the gel wet weight decreased (to 57% of original wet weight versus 86% for controls, P = < 0.001) and hyaluronan was completely depolymerized. Chondroitin ABC lyase digestion (0.2 U/gel) resulted in a slight reduction in gel wet weight (90% versus 96%, P = < 0.001) and depolymerization of 88% of the hyaluronan; the presence of fully digested chondroitin sulfate chains was established. Digestions with 100 and 500 U/gel of testicular hyaluronidase resulted in a decrease (P = < 0.001, both cases) in gel wet weight (53% versus 82%, 100 U/gel; 57%, versus 86%, 500 U/gel) with 75% and 97% hyaluronan depolymerization, respectively. CONCLUSIONS: Depolymerization of all vitreous hyaluronan and of chondroitin sulfate resulted in gel wet weight reduction but not gel destruction. Digestion with 30 U/gel of Streptomyces hyaluronan lyase revealed a small pool (6%) of relatively enzyme-resistant hyaluronan that specifically contributed toward maintaining gel wet weight.  (+info)

Identification of a nervous tissue-specific chondroitin sulfate proteoglycan, neurocan, in developing rat retina. (8/194)

PURPOSE: To identify the expression of neurocan, a nervous tissue-specific chondroitin sulfate proteoglycan, in retina and to elucidate its changes during development. METHODS: Expressional changes of neurocan mRNAs in developing rat retinas were investigated by a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). The localization and characterization of neurocan core proteins were also investigated with the use of Western blot analysis and immunohistochemistry. RESULTS: Gene expression of neurocan was identified in retinas by RT-PCR. Semiquantitative analysis using Southern blot analysis revealed that mRNA expression for neurocan increased at increasing postnatal stages and that it reached its peak around postnatal day 7 (P7). Immunohistochemical studies demonstrated that in differentiating rat retinal (neuroblast) cells weak neurocan immunoreactivities were observed throughout the retina on embryonal days 14 (E14) and E16. During the early postnatal period, the immunoreactivities became most conspicuous in the inner and outer plexiform layers on P7 through P14. In adult retinas, only faint immunostaining was detected. Immunoblot analysis showed two positive bands of 220- and 150-kDa core glycoproteins after treatment with chondroitinase ABC. Further immunoblot analysis revealed that the expression of these two immunolabeled variants was regulated differently during retinal development. CONCLUSIONS: The temporal and spatial regulation of expression of neurocan and its proteolytic variant during retinal development suggest that it may play a role in differentiation and neural network formation.  (+info)

Chondroitin ABC lyase, also known as chondroitinase ABC or chondroitin sulfate eliminase, is an enzyme that breaks down chondroitin sulfate proteoglycans (CSPGs), which are major components of the extracellular matrix in various tissues including cartilage. CSPGs contain chondroitin sulfate chains, which are long, negatively charged polysaccharides composed of alternating sugars (N-acetylgalactosamine and glucuronic acid) with sulfate groups attached at specific positions.

Chondroitin ABC lyase cleaves chondroitin sulfate chains by removing a disaccharide unit from the polymer, resulting in the formation of unsaturated bonds between the remaining sugars. This enzymatic activity has been used in research to study the structure and function of CSPGs and their role in various biological processes, such as cell migration, tissue repair, and neural plasticity. Additionally, chondroitin ABC lyase has potential therapeutic applications for treating conditions associated with excessive accumulation of CSPGs, such as fibrosis and some neurological disorders.

Chondroitin lyases are a group of enzymes that breakdown chondroitin, which is a type of proteoglycan found in connective tissues such as cartilage. These enzymes cleave chondroitin at specific points by removing certain sugar units, thereby breaking down the large, complex molecule into smaller fragments. Chondroitin lyases are classified based on their site of action and the type of fragment they produce. They play important roles in various biological processes, including tissue remodeling, growth, and development. In some cases, chondroitin lyases may also be used in research and medical settings to study the structure and function of proteoglycans or for the production of smaller chondroitin fragments with therapeutic potential.

Chondroitin sulfates are a type of complex carbohydrate molecules known as glycosaminoglycans (GAGs). They are a major component of cartilage, the tissue that cushions and protects the ends of bones in joints. Chondroitin sulfates are composed of repeating disaccharide units made up of glucuronic acid and N-acetylgalactosamine, which can be sulfated at various positions.

Chondroitin sulfates play a crucial role in the biomechanical properties of cartilage by attracting water and maintaining the resiliency and elasticity of the tissue. They also interact with other molecules in the extracellular matrix, such as collagen and proteoglycans, to form a complex network that provides structural support and regulates cell behavior.

Chondroitin sulfates have been studied for their potential therapeutic benefits in osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage. Supplementation with chondroitin sulfate has been shown to reduce pain and improve joint function in some studies, although the evidence is not consistent across all trials. The mechanism of action is thought to involve inhibition of enzymes that break down cartilage, as well as stimulation of cartilage repair and synthesis.

Dermatan sulfate is a type of glycosaminoglycan, which is a long, unbranched sugar chain found on the proteoglycan core protein in the extracellular matrix of animal tissues. It is composed of repeating disaccharide units of iduronic acid and N-acetylgalactosamine, with alternating sulfation at the 4-position of the iduronic acid and the 6-position of the galactosamine.

Dermatan sulfate is found in various tissues, including skin, heart valves, and blood vessels, where it plays important roles in regulating cell behavior, tissue development, and homeostasis. It also binds to a variety of growth factors, cytokines, and enzymes, modulating their activities and contributing to the regulation of various biological processes.

Abnormalities in dermatan sulfate metabolism can lead to several genetic disorders, such as Hunter syndrome and Hurler-Scheie syndrome, which are characterized by skeletal abnormalities, cardiac defects, and neurological impairment.

Chondroitin is a type of molecule known as a glycosaminoglycan, which is found in the connective tissues of the body, including cartilage. It is a major component of proteoglycans, which are complex molecules that provide structural support and help retain water within the cartilage, allowing it to function as a cushion between joints.

Chondroitin sulfate, a form of chondroitin, is commonly used in dietary supplements for osteoarthritis, a condition characterized by the breakdown of cartilage in joints. The idea behind using chondroitin sulfate as a treatment for osteoarthritis is that it may help to rebuild damaged cartilage and reduce inflammation in the affected joints. However, research on the effectiveness of chondroitin sulfate for osteoarthritis has had mixed results, with some studies showing modest benefits while others have found no significant effects.

It's important to note that dietary supplements containing chondroitin are not regulated by the U.S. Food and Drug Administration (FDA) in the same way that drugs are, so the quality and purity of these products can vary widely. As with any supplement, it's a good idea to talk to your doctor before starting to take chondroitin, especially if you have any medical conditions or are taking other medications.

Chondroitin sulfate proteoglycans (CSPGs) are complex molecules found in the extracellular matrix of various connective tissues, including cartilage. They are composed of a core protein covalently linked to one or more glycosaminoglycan (GAG) chains, such as chondroitin sulfate and dermatan sulfate.

CSPGs play important roles in the structure and function of tissues, including:

1. Regulating water content and providing resilience to tissues due to their high negative charge, which attracts cations and bound water molecules.
2. Interacting with other matrix components, such as collagen and elastin, to form a highly organized network that provides tensile strength and elasticity.
3. Modulating cell behavior by interacting with various growth factors, cytokines, and cell surface receptors, thereby influencing processes like cell adhesion, proliferation, differentiation, and migration.
4. Contributing to the maintenance of the extracellular matrix homeostasis through their involvement in matrix turnover and remodeling.

In articular cartilage, CSPGs are particularly abundant and contribute significantly to its load-bearing capacity and overall health. Dysregulation of CSPGs has been implicated in various pathological conditions, such as osteoarthritis, where altered proteoglycan composition and content can lead to cartilage degradation and joint dysfunction.

Glycosaminoglycans (GAGs) are long, unbranched polysaccharides composed of repeating disaccharide units. They are a major component of the extracellular matrix and connective tissues in the body. GAGs are negatively charged due to the presence of sulfate and carboxyl groups, which allows them to attract positively charged ions and water molecules, contributing to their ability to retain moisture and maintain tissue hydration and elasticity.

GAGs can be categorized into four main groups: heparin/heparan sulfate, chondroitin sulfate/dermatan sulfate, keratan sulfate, and hyaluronic acid. These different types of GAGs have varying structures and functions in the body, including roles in cell signaling, inflammation, and protection against enzymatic degradation.

Heparin is a highly sulfated form of heparan sulfate that is found in mast cells and has anticoagulant properties. Chondroitin sulfate and dermatan sulfate are commonly found in cartilage and contribute to its resiliency and ability to withstand compressive forces. Keratan sulfate is found in corneas, cartilage, and bone, where it plays a role in maintaining the structure and function of these tissues. Hyaluronic acid is a large, nonsulfated GAG that is widely distributed throughout the body, including in synovial fluid, where it provides lubrication and shock absorption for joints.

Proteoglycans are complex, highly negatively charged macromolecules that are composed of a core protein covalently linked to one or more glycosaminoglycan (GAG) chains. They are a major component of the extracellular matrix (ECM) and play crucial roles in various biological processes, including cell signaling, regulation of growth factor activity, and maintenance of tissue structure and function.

The GAG chains, which can vary in length and composition, are long, unbranched polysaccharides that are composed of repeating disaccharide units containing a hexuronic acid (either glucuronic or iduronic acid) and a hexosamine (either N-acetylglucosamine or N-acetylgalactosamine). These GAG chains can be sulfated to varying degrees, which contributes to the negative charge of proteoglycans.

Proteoglycans are classified into four major groups based on their core protein structure and GAG composition: heparan sulfate/heparin proteoglycans, chondroitin/dermatan sulfate proteoglycans, keratan sulfate proteoglycans, and hyaluronan-binding proteoglycans. Each group has distinct functions and is found in specific tissues and cell types.

In summary, proteoglycans are complex macromolecules composed of a core protein and one or more GAG chains that play important roles in the ECM and various biological processes, including cell signaling, growth factor regulation, and tissue structure maintenance.

Decorin is a small proteoglycan, a type of protein with a attached sugar chain, that is found in the extracellular matrix of connective tissues in the body. It is composed of a core protein and one or more glycosaminoglycan (GAG) chains, specifically dermatan sulfate. Decorin plays important roles in the organization and biomechanical properties of collagen fibrils, regulation of cell proliferation and migration, and modulation of growth factor activity. It has been studied for its potential role in various physiological and pathological processes, including wound healing, fibrosis, and cancer.

In the context of medicine and biology, sulfates are ions or compounds that contain the sulfate group (SO4−2). Sulfate is a polyatomic anion with the structure of a sphere. It consists of a central sulfur atom surrounded by four oxygen atoms in a tetrahedral arrangement.

Sulfates can be found in various biological molecules, such as glycosaminoglycans and proteoglycans, which are important components of connective tissue and the extracellular matrix. Sulfate groups play a crucial role in these molecules by providing negative charges that help maintain the structural integrity and hydration of tissues.

In addition to their biological roles, sulfates can also be found in various medications and pharmaceutical compounds. For example, some laxatives contain sulfate salts, such as magnesium sulfate (Epsom salt) or sodium sulfate, which work by increasing the water content in the intestines and promoting bowel movements.

It is important to note that exposure to high levels of sulfates can be harmful to human health, particularly in the form of sulfur dioxide (SO2), a common air pollutant produced by burning fossil fuels. Prolonged exposure to SO2 can cause respiratory problems and exacerbate existing lung conditions.

Sulfur radioisotopes are unstable forms of the element sulfur that emit radiation as they decay into more stable forms. These isotopes can be used in medical imaging and treatment, such as in the detection and treatment of certain cancers. Common sulfur radioisotopes used in medicine include sulfur-35 and sulfur-32. Sulfur-35 is used in research and diagnostic applications, while sulfur-32 is used in brachytherapy, a type of internal radiation therapy. It's important to note that handling and usage of radioisotopes should be done by trained professionals due to the potential radiation hazards they pose.

Chondroitinases and chondroitin lyases are enzymes that break down chondroitin sulfate, a type of glycosaminoglycan (GAG) found in connective tissues such as cartilage. Glycosaminoglycans are long, unbranched polysaccharides made up of repeating disaccharide units. In the case of chondroitin sulfate, the disaccharide unit consists of a glucuronic acid residue and a N-acetylgalactosamine residue that may be sulfated at various positions.

Chondroitinases are enzymes that cleave the linkage between the two sugars in the chondroitin sulfate chain, specifically between the carbon atom in the fourth position of the glucuronic acid and the nitrogen atom in the first position of the N-acetylgalactosamine. This results in the formation of unsaturated disaccharides. Chondroitinases are produced by certain bacteria and are used in research to study the structure and function of chondroitin sulfate and other GAGs.

Chondroitin lyases, on the other hand, are enzymes that cleave the same linkage but in the opposite direction, resulting in the formation of 4,5-unsaturated disaccharides. Chondroitin lyases are also produced by certain bacteria and are used in research to study the structure and function of chondroitin sulfate and other GAGs.

It is important to note that while both chondroitinases and chondroitin lyases break down chondroitin sulfate, they do so through different mechanisms and produce different products.

Extracellular matrix (ECM) proteins are a group of structural and functional molecules that provide support, organization, and regulation to the cells in tissues and organs. The ECM is composed of a complex network of proteins, glycoproteins, and carbohydrates that are secreted by the cells and deposited outside of them.

ECM proteins can be classified into several categories based on their structure and function, including:

1. Collagens: These are the most abundant ECM proteins and provide strength and stability to tissues. They form fibrils that can withstand high tensile forces.
2. Proteoglycans: These are complex molecules made up of a core protein and one or more glycosaminoglycan (GAG) chains. The GAG chains attract water, making proteoglycans important for maintaining tissue hydration and resilience.
3. Elastin: This is an elastic protein that allows tissues to stretch and recoil, such as in the lungs and blood vessels.
4. Fibronectins: These are large glycoproteins that bind to cells and ECM components, providing adhesion, migration, and signaling functions.
5. Laminins: These are large proteins found in basement membranes, which provide structural support for epithelial and endothelial cells.
6. Tenascins: These are large glycoproteins that modulate cell adhesion and migration, and regulate ECM assembly and remodeling.

Together, these ECM proteins create a microenvironment that influences cell behavior, differentiation, and function. Dysregulation of ECM proteins has been implicated in various diseases, including fibrosis, cancer, and degenerative disorders.

Polysaccharide-lyases are a class of enzymes that cleave polysaccharides through a β-elimination mechanism, leading to the formation of unsaturated sugars. These enzymes are also known as depolymerizing enzymes and play an essential role in the breakdown and modification of complex carbohydrates found in nature. They have important applications in various industries such as food, pharmaceuticals, and biofuels.

Polysaccharide-lyases specifically target polysaccharides containing uronic acid residues, such as pectins, alginates, and heparin sulfate. The enzymes cleave the glycosidic bond between two sugar residues by breaking the alpha configuration at carbon 4 of the uronic acid residue, resulting in a double bond between carbons 4 and 5 of the non-reducing end of the polysaccharide chain.

Polysaccharide-lyases are classified into several subclasses based on their substrate specificity and reaction mechanism. These enzymes have potential therapeutic applications, such as in the treatment of bacterial infections, cancer, and other diseases associated with abnormal glycosylation.

Disaccharides are a type of carbohydrate that is made up of two monosaccharide units bonded together. Monosaccharides are simple sugars, such as glucose, fructose, or galactose. When two monosaccharides are joined together through a condensation reaction, they form a disaccharide.

The most common disaccharides include:

* Sucrose (table sugar), which is composed of one glucose molecule and one fructose molecule.
* Lactose (milk sugar), which is composed of one glucose molecule and one galactose molecule.
* Maltose (malt sugar), which is composed of two glucose molecules.

Disaccharides are broken down into their component monosaccharides during digestion by enzymes called disaccharidases, which are located in the brush border of the small intestine. These enzymes catalyze the hydrolysis of the glycosidic bond that links the two monosaccharides together, releasing them to be absorbed into the bloodstream and used for energy.

Disorders of disaccharide digestion and absorption can lead to various symptoms, such as bloating, diarrhea, and abdominal pain. For example, lactose intolerance is a common condition in which individuals lack sufficient levels of the enzyme lactase, leading to an inability to properly digest lactose and resulting in gastrointestinal symptoms.

Adenylosuccinate Lyase is a crucial enzyme in the purine nucleotide biosynthesis pathway. Its primary function is to catalyze the conversion of adenylosuccinate into adenosine monophosphate (AMP) and fumarate in two consecutive steps. This enzyme plays an essential role in the metabolism of purines, which are vital components of DNA, RNA, and energy transfer molecules like ATP. Deficiency in this enzyme can lead to a rare genetic disorder known as Adenylosuccinase Deficiency or Adenylosuccinate Lyase Deficiency, characterized by neurological symptoms, developmental delays, and physical disabilities.

Hyaluronic acid is a glycosaminoglycan, a type of complex carbohydrate, that is naturally found in the human body. It is most abundant in the extracellular matrix of soft connective tissues, including the skin, eyes, and joints. Hyaluronic acid is known for its remarkable capacity to retain water, which helps maintain tissue hydration, lubrication, and elasticity. Its functions include providing structural support, promoting wound healing, and regulating cell growth and differentiation. In the medical field, hyaluronic acid is often used in various forms as a therapeutic agent for conditions like osteoarthritis, dry eye syndrome, and skin rejuvenation.

Oxo-acid lyases are a class of enzymes that catalyze the cleavage of a carbon-carbon bond in an oxo-acid to give a molecule with a carbonyl group and a carbanion, which then reacts non-enzymatically with a proton to form a new double bond. The reaction is reversible, and the enzyme can also catalyze the reverse reaction.

Oxo-acid lyases play important roles in various metabolic pathways, such as the citric acid cycle, glyoxylate cycle, and the degradation of certain amino acids. These enzymes are characterized by the presence of a conserved catalytic mechanism involving a nucleophilic attack on the carbonyl carbon atom of the oxo-acid substrate.

The International Union of Biochemistry and Molecular Biology (IUBMB) has classified oxo-acid lyases under EC 4.1.3, which includes enzymes that catalyze the formation of a carbon-carbon bond by means other than carbon-carbon bond formation to an enolate or carbonion, a carbanionic fragment, or a Michael acceptor.

Heparin sulfate is not exactly referred to as "heparitin sulfate" in medical terminology. The correct term is heparan sulfate, which is a type of glycosaminoglycan (GAG), a long unbranched chain of repeating disaccharide units composed of a hexuronic acid and a hexosamine.

Heparan sulfate is found on the cell surface and in the extracellular matrix, where it plays crucial roles in various biological processes, including cell signaling, regulation of growth factor activity, and control of blood coagulation. It is also an important component of the proteoglycans, which are complex molecules that help to maintain the structural integrity and function of tissues and organs.

Like heparin, heparan sulfate has a high negative charge due to the presence of sulfate groups, which allows it to bind to and interact with various proteins and growth factors. However, heparan sulfate has a more diverse structure than heparin, with variations in the pattern of sulfation along the chain, which leads to specificity in its interactions with different proteins.

Defects in heparan sulfate biosynthesis or function have been implicated in various human diseases, including certain forms of cancer, developmental disorders, and infectious diseases.

Cartilage is a type of connective tissue that is found throughout the body in various forms. It is made up of specialized cells called chondrocytes, which are embedded in a firm, flexible matrix composed of collagen fibers and proteoglycans. This unique structure gives cartilage its characteristic properties of being both strong and flexible.

There are three main types of cartilage in the human body: hyaline cartilage, elastic cartilage, and fibrocartilage.

1. Hyaline cartilage is the most common type and is found in areas such as the articular surfaces of bones (where they meet to form joints), the nose, trachea, and larynx. It has a smooth, glassy appearance and provides a smooth, lubricated surface for joint movement.
2. Elastic cartilage contains more elastin fibers than hyaline cartilage, which gives it greater flexibility and resilience. It is found in structures such as the external ear and parts of the larynx and epiglottis.
3. Fibrocartilage has a higher proportion of collagen fibers and fewer chondrocytes than hyaline or elastic cartilage. It is found in areas that require high tensile strength, such as the intervertebral discs, menisci (found in joints like the knee), and the pubic symphysis.

Cartilage plays a crucial role in supporting and protecting various structures within the body, allowing for smooth movement and providing a cushion between bones to absorb shock and prevent wear and tear. However, cartilage has limited capacity for self-repair and regeneration, making damage or degeneration of cartilage tissue a significant concern in conditions such as osteoarthritis.

I'm sorry for any confusion, but "Hyaluronoglucosaminidase" appears to be a made-up term or a typographical error. The correct term related to hyaluronic acid metabolism is "hyaluronidase," which is an enzyme that degrades hyaluronic acid, a component of the extracellular matrix in various tissues. If you meant to ask about this enzyme or its functions, I'd be happy to provide more information on that. However, if "Hyaluronoglucosaminidase" is intended to represent another medical term, could you please clarify so I can provide an accurate and helpful response?

Keratan sulfate is a type of glycosaminoglycan (GAG), which is a complex carbohydrate found in connective tissues, including the cornea and cartilage. It is composed of repeating disaccharide units of galactose and N-acetylglucosamine, with sulfate groups attached to some of the sugar molecules.

Keratan sulfate is unique among GAGs because it contains a high proportion of non-sulfated sugars and is often found covalently linked to proteins in structures called proteoglycans. In the cornea, keratan sulfate plays important roles in maintaining transparency and regulating hydration. In cartilage, it contributes to the elasticity and resilience of the tissue.

Abnormalities in keratan sulfate metabolism have been associated with several genetic disorders, including corneal dystrophies and skeletal dysplasias.

A lyase is a type of enzyme that catalyzes the breaking of various chemical bonds in a molecule, often resulting in the formation of two new molecules. Lyases differ from other types of enzymes, such as hydrolases and oxidoreductases, because they create double bonds or rings as part of their reaction mechanism.

In the context of medical terminology, lyases are not typically discussed on their own, but rather as a type of enzyme that can be involved in various biochemical reactions within the body. For example, certain lyases play a role in the metabolism of carbohydrates, lipids, and amino acids, among other molecules.

One specific medical application of lyase enzymes is in the diagnosis of certain genetic disorders. For instance, individuals with hereditary fructose intolerance (HFI) lack the enzyme aldolase B, which is a type of lyase that helps break down fructose in the liver. By measuring the activity of aldolase B in a patient's blood or tissue sample, doctors can diagnose HFI and recommend appropriate dietary restrictions to manage the condition.

Overall, while lyases are not a medical diagnosis or condition themselves, they play important roles in various biochemical processes within the body and can be useful in the diagnosis of certain genetic disorders.

Sulfotransferases (STs) are a group of enzymes that play a crucial role in the process of sulfoconjugation, which is the transfer of a sulfo group (-SO3H) from a donor molecule to an acceptor molecule. These enzymes are widely distributed in nature and are found in various organisms, including humans.

In humans, STs are involved in the metabolism and detoxification of numerous xenobiotics, such as drugs, food additives, and environmental pollutants, as well as endogenous compounds, such as hormones, neurotransmitters, and lipids. The sulfoconjugation reaction catalyzed by STs can increase the water solubility of these compounds, facilitating their excretion from the body.

STs can be classified into several families based on their sequence similarity and cofactor specificity. The largest family of STs is the cytosolic sulfotransferases, which use 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a cofactor to transfer the sulfo group to various acceptor molecules, including phenols, alcohols, amines, and steroids.

Abnormalities in ST activity have been implicated in several diseases, such as cancer, cardiovascular disease, and neurological disorders. Therefore, understanding the function and regulation of STs is essential for developing new therapeutic strategies to treat these conditions.

Aldehyde-lyases are a class of enzymes that catalyze the breakdown or synthesis of molecules involving an aldehyde group through a reaction known as lyase cleavage. This type of reaction results in the removal of a molecule, typically water or carbon dioxide, from the substrate.

In the case of aldehyde-lyases, these enzymes specifically catalyze reactions that involve the conversion of an aldehyde into a carboxylic acid or vice versa. These enzymes are important in various metabolic pathways and play a crucial role in the biosynthesis and degradation of several biomolecules, including carbohydrates, amino acids, and lipids.

The systematic name for this class of enzymes is "ald(e)hyde-lyases." They are classified under EC number 4.3.1 in the Enzyme Commission (EC) system.

Uronic acids are a type of organic compound that are carboxylic acids derived from sugars (carbohydrates). They are formed by the oxidation of the primary alcohol group (-CH2OH) on a pentose sugar, resulting in a carboxyl group (-COOH) at that position.

The most common uronic acid is glucuronic acid, which is derived from glucose. Other examples include galacturonic acid (derived from galactose), iduronic acid (derived from glucose or galactose), and mannuronic acid (derived from mannose).

Uronic acids play important roles in various biological processes, such as the formation of complex carbohydrates like glycosaminoglycans, which are major components of connective tissues. They also serve as important intermediates in the metabolism of sugars and other carbohydrates.

Versican is a type of proteoglycan, which is a complex protein molecule that contains one or more long sugar chains (glycosaminoglycans) attached to it. Proteoglycans are important components of the extracellular matrix (the material that provides structural support and regulates cell behavior in tissues and organs).

Versican is primarily found in the extracellular matrix of connective tissues, including skin, tendons, ligaments, and blood vessels. It plays a role in regulating cell adhesion, migration, and proliferation, as well as in maintaining the structural integrity of tissues. Versican has been implicated in various physiological and pathological processes, such as embryonic development, wound healing, inflammation, and cancer progression.

There are several isoforms of versican (V0, V1, V2, and V3) that differ in their structure and function, depending on the specific glycosaminoglycan chains attached to them. Abnormal expression or regulation of versican has been associated with various diseases, including cancer, fibrosis, and inflammatory disorders.

Aggrecan is a large, complex proteoglycan molecule found in the extracellular matrix of articular cartilage and other connective tissues. It is a key component of the structural framework of these tissues, helping to provide resiliency, cushioning, and protection to the cells within. Aggrecan contains numerous glycosaminoglycan (GAG) chains, which are negatively charged molecules that attract water and ions, creating a swelling pressure that contributes to the tissue's load-bearing capacity.

The medical definition of 'Aggrecans' can be described as:

1. A large proteoglycan molecule found in articular cartilage and other connective tissues.
2. Composed of a core protein with attached glycosaminoglycan (GAG) chains, primarily chondroitin sulfate and keratan sulfate.
3. Plays a crucial role in the biomechanical properties of articular cartilage by attracting water and ions, creating a swelling pressure that contributes to the tissue's load-bearing capacity.
4. Aggrecan degradation or loss is associated with various joint diseases, such as osteoarthritis, due to reduced structural integrity and shock-absorbing capabilities of articular cartilage.

Chondroitin ABC lyase (EC 4.2.2.20 EC 4.2.2.21, chondroitinase, chondroitin ABC eliminase, chondroitinase ABC) is an enzyme ... Chondroitin+ABC+lyase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (Wikipedia ... with systematic name chondroitin ABC lyase. This enzyme catalyses the following chemical reaction Eliminative degradation of ... chondroitin 6-sulfate and dermatan sulfate. Following a spinal cord injury, this enzyme can be used to erode scar tissue that ...
... correlating with altered PNN-associated sulfation patterns of chondroitin sulfate glycosaminoglycans in the MBH. Each of these ... Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially ... Chondroitin 6-sulphate synthesis is upregulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth ... Quantitative analysis of chondroitin sulfate disaccharides from human and rodent fixed brain tissue by electrospray ionization- ...
... chondroitin ABC lyase and heparinase III, produced an even greater enhancement in retinal transduction. Chondroitin ABC lyase ... Collagenase, hyaluronan lyase, chondroitin ABC lyase, and heparinase III were coinjected with AAV2.CBA.eGFP and retinal ... hyaluronan lyase from Streptomyces (E.C. 4.2.2.1), which has a high specificity for hyaluronan; Chondroitin ABC lyase (E.C. 4.2 ... but chondroitin ABC lyase, heparinase III and, to a lesser extent, hyaluronan lyase increased expression of the viral reporter ...
Chondroitin ABC Lyase Medicine & Life Sciences 100% * Glial Cell Line-Derived Neurotrophic Factor Medicine & Life Sciences 88% ... with the digestion of inhibitory CSPGs in the distal denervated nerve using sustained lentiviral-mediated chondroitinase ABC ( ... with the digestion of inhibitory CSPGs in the distal denervated nerve using sustained lentiviral-mediated chondroitinase ABC ( ... with the digestion of inhibitory CSPGs in the distal denervated nerve using sustained lentiviral-mediated chondroitinase ABC ( ...
Chondroitin ABC Lyase Medicine & Life Sciences 100% * Nanospheres Medicine & Life Sciences 99% ... A formulation including injectable biodegradable nanospheres and/or microspheres as a delivery system for chondroitinase ABC ( ... "A formulation including injectable biodegradable nanospheres and/or microspheres as a delivery system for chondroitinase ABC ( ... A formulation including injectable biodegradable nanospheres and/or microspheres as a delivery system for chondroitinase ABC ( ...
Chondroitinases and Chondroitin Lyases 100% * Chondroitin ABC Lyase 92% * Nerve Tissue 70% ... Effects of chondroitinase ABC on intrathecal and peripheral nerve tissue. An in vivo experimental study on rabbits. Olmarker, K ...
Chondroitin ABC Lyase 100% * Copolymers 79% * Regeneration 56% * Copolymer 44% * Proteoglycans 28% ... Machine-Assisted Discovery of Chondroitinase ABC Complexes toward Sustained Neural Regeneration. Kosuri, S., Borca, C. H., ...
DNA-(apurinic or apyrimidinic site) lyase activity GO:0003906 * chondroitin-sulfate-ABC endolyase activity ...
chondroitin abc lyase (1) * chondroitin sulfates (1) * heparin (1) * immunoglobulin g (1) ...
Composite active site of chondroitin lyase ABC accepting both epimers of uronic acid 9 ... Composite active site of chondroitin lyase ABC accepting both epimers of uronic acid ... ArthroAC, Arthrobacter aurescens chondroitinase AC; BactnABC, Bacteroides thetaiotaomicron chondroitinase ABC; chonABC, ...
Liquid Chromatography-Mass Spectrometry to Study Chondroitin Lyase Action Pattern  Zhang, Zhenqing; Park, Youmie; Kemp, ... Two commercial enzymes, chondroitinase ABC (Proteus vulgaris) and chondroitinase ACII (Arthrobacter .... * Liquid to liquid ... Liquid chromatography-mass spectrometry was applied to determine the action pattern of different chondroitin lyases. ...
chondroitin-sulfate-ABC exolyase activity GO:0034001 * fatty acid in-chain hydroxylase activity ...
Digestion of the CS proteoglycan with chondroitinase ABC lyase, followed by SDS/PAGE, yielded a protein core of 600 to 700 kDa ... and was substituted with 15-20 chondroitin sulphate (CS) chains (Mr 60000-65000). Half of the CS disaccharides were 6-sulphated ...
Chondroitin ABC Lyase. *Chondroitin Sulfate Proteoglycans. *Chronic Pain. *Clinical Competence. *Clinical Laboratory Techniques ...
... a real-world experience Chondroitin 6-sulphate is required for neuroplasticity and memory in ageing Dynamic loading of human ... sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production Dynamically and ... pancreatic islets and prevents β cell death via ATG16L1 interaction and autophagy regulation Conformational dynamics of the ABC ... solution under subnormothermic conditions Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC ...
... erotic tone forever hd dragon ethics collectables fantastic busy captain imagine leg heating brings neck wing governments abc ... tomball eib scleroderma mrf minka prinz nita umkc bacardi menominee curiae riveted contv offi rodolfo winemaker digicam lyase ... geochemistry anth clinging backseat expertly tioga aylesbury vamp submenu lpc internationals coiled yucatan chondroitin durand ... htl goodall sprites unjustified ecnext ranchi fertiliser exotics masala articulating jiffy multinationals woodbine busines abcs ...
Chondroitin ABC lyase Chondroitin AC Lyase,Chondroitin AC Lyase Chondroitin AC ... Chondroitin ABC,Lyase, Chondroitin ABC Lyase ... Chondroitin ABC lyase Chondroitin AC Lyase,Chondroitin AC Lyase Chondroitin AC ... Chondroitin ABC,Lyase, Chondroitin ABC Lyase ... Lyase, Chondroitin AC Lyase, Chondroitin B,Lyase, Chondroitin B ... cathepsin B chondroitin ABC lyase,chondroitin ABC lyase ... Lyase, Chondroitin AC Lyase, Chondroitin B,Lyase, Chondroitin B ... cathepsin B chondroitin ABC lyase,chondroitin ABC lyase ...
Chondroitin ABC Lyase / genetics* Actions. * Search in PubMed * Search in MeSH * Add to Search ... ABC is a bacterial enzyme that cleaves chondroitin sulfate disaccharide chains from CSPGs in the tumor ECM. Wild-type Chase ABC ... Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide Alena Cristina Jaime-Ramirez 1 , Nina Dmitrieva 1 , ... Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide Alena Cristina Jaime-Ramirez et al. J Gene Med. 2017 ...
... in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.. Tsukifuji R; Sakai Y; Hatamochi A; Shinkai H. ...
Chondroitin ABC lyase (substance). Code System Preferred Concept Name. Chondroitin ABC lyase (substance). ... Enzyme (substance) {90668006 , SNOMED-CT } Substance with lyase mechanism of action (substance) {21533003 , SNOMED-CT } ... Chondroitin ABC lyase Current Synonym true false 40852019 Chondroitin ABC eliminase Current Synonym true false ...
Chondroitine ABC lyase Entry term(s):. Chondroitin Sulfate ABC Endolyase. Chondroitin-Sulfate-ABC Endolyase. Chondroitinase ABC ... Chondroitin ABC Lyase - Preferred Concept UI. M0029328. Scope note. An enzyme that catalyzes the eliminative degradation of ... Chondroitin ABC Lyase Entry term(s). Chondroitin Sulfate ABC Endolyase Chondroitin-Sulfate-ABC Endolyase Chondroitinase ABC ... do not confuse with CHONDROITIN LYASES. Allowable Qualifiers:. AD administration & dosage. AE adverse effects. AI antagonists ...
These HABPs specific binding was sensitive to HeLa and HepG2 cells pre-treatment with heparinase I and chondroitinase ABC. ... Chondroitin abc lyase ,. Hela cells ,. Hep g2 cells ,. Heparin lyase ,. Hepatocytes ,. Humans ,. Malaria vaccines ,. Peptides , ... Heparin lyase ,. High activity binding peptide ,. Malaria vaccine ,. Protozoal protein ,. Synthetic peptide ,. Thrombospondin ... These HABPs specific binding was sensitive to HeLa and HepG2 cells pre-treatment with heparinase I and chondroitinase ABC. ...
chondroitin ABC lyase. Public MeSH Note. 98; see CHONDROITIN LYASES 1975-97. History Note. 98; use CHONDROITIN LYASES 1975-97. ... Chondroitin Lyases [D08.811.520.241.700.350.500] * Chondroitin ABC Lyase [D08.811.520.241.700.350.500.500] ... Carbon-Oxygen Lyases [D08.811.520.241] * Polysaccharide-Lyases [D08.811.520.241.700] * Chondroitinases and Chondroitin Lyases [ ... Chondroitin ABC Lyase Preferred Term Term UI T058755. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1998). ...
chondroitin ABC lyase. Public MeSH Note. 98; see CHONDROITIN LYASES 1975-97. History Note. 98; use CHONDROITIN LYASES 1975-97. ... Chondroitin Lyases [D08.811.520.241.700.350.500] * Chondroitin ABC Lyase [D08.811.520.241.700.350.500.500] ... Carbon-Oxygen Lyases [D08.811.520.241] * Polysaccharide-Lyases [D08.811.520.241.700] * Chondroitinases and Chondroitin Lyases [ ... Chondroitin ABC Lyase Preferred Term Term UI T058755. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1998). ...
chondroitin ABC lyase activity GO:0047486 * glycine dehydrogenase activity GO:0047960 * NADPH-hemoprotein reductase activity ...
Sulfatase N0000005998 Chondroitin N0000168038 Chondroitin ABC Lyase N0000168037 Chondroitin Lyases N0000169197 Chondroitin ... Sulfate Proteoglycans N0000010542 Chondroitin Sulfates N0000168036 Chondroitinases and Chondroitin Lyases N0000167602 ... as Amide-N-Donor N0000168008 Carbon-Nitrogen Lyases N0000167775 Carbon-Oxygen Ligases N0000008169 Carbon-Oxygen Lyases ... Lyase N0000168230 DNA-Activated Protein Kinase N0000169224 DNA-Binding Proteins N0000180242 DNA-Cytosine Methylases N0000168286 ...
Hamai A, Hashimoto N, Mochizuki H, Kato F, Makiguchi Y, Horie K, Suzuki S. Two distinct chondroitin sulfate ABC lyases. An ... Chondroitinase ABC) is an eliminase that degrades chondroitin sulfate and hyaluronic acid, which are glycosaminoglycans of ... Eurell JA, Brown MD, Ramos M. The effects of chondroitinase ABC on the rabbit intervertebral disc. A roentgenographic and ... Kato F, Iwata H, Mimatsu K, Miura T. Experimental chemonucleolysis with chondroitinase ABC. Clin Orthop Relat Res. 1990;253:301 ...
A Highly Active Chondroitin Sulfate Lyase ABC for Enzymatic Depolymerization of Chondroitin Sulfate fan;, xiao-man ... In this work, a chondroitin sulfate lyase ABC (Chon-ABC) was successfully cloned, expressed, and characterized. The Km and Vmax ... Enzymatic preparation of low-molecular-weight chondroitin sulfate (LMWCS) has received increasing attention. ... of the Chon-ABC were 0.54 mM and 541.3 U mg−1, respectively. The maximal activity was assayed as 500.4 U mg−1 at ... ...
In this work, a chondroitin sulfate lyase ABC (Chon-ABC) was successfully cloned, expressed, and characterized. The Km and Vmax ... A Highly Active Chondroitin Sulfate Lyase ABC for Enzymatic Depolymerization of Chondroitin Sulfate. ... Chondroitin AC lyase can hydrolyze chondroitin sulfate A (CS-A), chondroitin sulfate C (CS-C), and hyaluronic acid (HA), making ... Chondroitin AC lyase can efficiently hydrolyze chondroitin sulfate (CS) to low molecule weight chondroitin sulfate, which has ...
G11.427.792.560.180 Chondroitin ABC Lyase D8.586.520.241.700.350.500.500 D8.811.520.241.700.350.500.500 Chondroitin Lyases ... D8.811.520.241.700.350.500 Chondroitinases and Chondroitin Lyases D8.586.277.352.827.180 D8.811.277.352.827.180 D8.586.520.241. ... D8.811.913.200 Aldehyde-Lyases D8.586.520.224.62 D8.811.520.224.62 Aldose-Ketose Isomerases D8.586.399.475.200 D8.811.399.475. ... G9.188.229.552 Lyases D8.586.520 D8.811.520 Lymecycline D4.615.638.638.900.450 Lymnaea B1.644.776.645 B1.500.644.776.645 Lymph ...
Family members include chondroitin AC lyase, chondroitin abc lyase, xanthan lyase, and hyalurate lyase. ... Substrates include chondroitin, chondroitin 4-sulfate, chondroitin 6-sulfate, and hyaluronic acid. ... A The X-ray structure of the Streptomyces coelicolor A3 Chondroitin AC Lyase in Complex with Chondroitin sulphate [Streptomyces ... Lyase_8_C 2.00e-10 885 947 1 65 Polysaccharide lyase family 8, C-terminal beta-sandwich domain. This family consists of a group ...
Chondroitin ABC eliminase Chondroitin ABC lyase,Chondroitin ABC lyase Chondroitin AC Lyase,Chondroitin AC Lyase Chondroitin AC ... Chondroitin ABC,Lyase, Chondroitin ABC Lyase, Chondroitin AC,Lyase, Chondroitin AC Lyase, Chondroitin B,Lyase, Chondroitin B ... cathepsin B chondroitin ABC lyase,chondroitin ABC lyase chondroitin AC lyase,chondroitin AC lyase chondroitin sulfate, ... Chondroitin AC eliminase Chondroitin AC lyase,Chondroitin AC lyase Chondroitin B Lyase,Chondroitin B Lyase Chondroitin ...
Chondroitin Chondroitin ABC Lyase Chondroitin Lyases Chondroitin Sulfate Proteoglycans Chondroitin Sulfates Chondroitinases and ... Carbon-Nitrogen Lyases Carbon-Oxygen Ligases Carbon-Oxygen Lyases Carbon-Sulfur Ligases Carbon-Sulfur Lyases Carbonated ... Chondroitin Lyases Chondroitinsulfatases Chondroma Chondromalacia Patellae Chondromatosis Chondromatosis, Synovial ... Lyase DNA-Activated Protein Kinase DNA-Binding Proteins DNA-Cytosine Methylases DNA-Directed DNA Polymerase DNA-Directed RNA ...
Chondroitin ABC eliminase Chondroitin ABC lyase,Chondroitin ABC lyase Chondroitin AC Lyase,Chondroitin AC Lyase Chondroitin AC ... Chondroitin ABC,Lyase, Chondroitin ABC Lyase, Chondroitin AC,Lyase, Chondroitin AC Lyase, Chondroitin B,Lyase, Chondroitin B ... cathepsin B chondroitin ABC lyase,chondroitin ABC lyase chondroitin AC lyase,chondroitin AC lyase chondroitin sulfate, ... Chondroitin AC eliminase Chondroitin AC lyase,Chondroitin AC lyase Chondroitin B Lyase,Chondroitin B Lyase Chondroitin ...
... chondroitin-6-sulfate transferase-1; CathD; cathepsin D; ChABS; chondroitinase ABC; ChGn-1; CS-beta-1,4,N- ... Keywords: هپاران سولفات; Heparan sulfate; Heparin lyase; Glucoasaminoglycan; Chromatographic analysis. دانلود رایگان متن کامل ... chondroitin sulfate; CSPG4; chondroitin sulfate proteoglycan 4; CXCL; CXC chemokine ligan ... chondroitin sulfate; KS; keratan sulfate; CSPG; chondroitin s ... chondroitin sulfate; DS; dextran sulfate; HS; heparan sulfate; ...
21249 Mori K, Naganuma T, Kihara A. Role of 2-hydroxy acyl-CoA lyase HACL2 in odd-chain fatty acid production via α-oxidation ... 13987 Kawaguchi K, Okamoto T, Morita M, Imanaka T. Translocation of the ABC transporter ABCD4 from the endoplasmic reticulum to ... chondroitin/dermatan sulfates, and hyaluronan disaccharides by glycoblotting-assisted sample preparation followed by single- ... 5428 Matsubasa T1, Takiguchi M, Matsuda I, Mori M. Rat argininosuccinate lyase promoter: the dyad-symmetric CCAAT box sequence ...
... a real-world experience Chondroitin 6-sulphate is required for neuroplasticity and memory in ageing Dynamic loading of human ... sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production Dynamically and ... pancreatic islets and prevents β cell death via ATG16L1 interaction and autophagy regulation Conformational dynamics of the ABC ... solution under subnormothermic conditions Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC ...

No FAQ available that match "chondroitin abc lyase"

No images available that match "chondroitin abc lyase"